The presence and role of the dopamine DA-2 receptor in the human decidua

J Obstet Gynaecol Res. 2000 Dec;26(6):449-54. doi: 10.1111/j.1447-0756.2000.tb01356.x.

Abstract

Objectives: Our objectives were to identify the presence of the dopamine DA-2 receptor in human decidua and to study its function in human parturition.

Methods: Human term decidual tissues were obtained during vaginal delivery and then homogenized. The P3 fraction was prepared for a radiolabeled receptor assay with [3H] spiperone as the ligand. Human decidual tissues obtained at cesarean section before the onset of labor were incubated in Krebs-Ringer buffer at 37 degrees C for 30 minutes in the presence of dopamine with or without (-)-sulpiride. The level of prostaglandin (PG) F in the medium was measured with a RIA kit. Differences were assessed with the Wilcoxon non-parametric test.

Results: Scatchard analysis showed a single class of binding sites having an equilibrium dissociation constant (Kd) of 2.25 +/- 0.59 nM (mean +/- SD) and a maximum binding capacity (Bmax) value of 166.5 +/- 77.7 fmol/mg protein (n = 3). Dopamine significantly increased the production of PGF. This stimulatory effect of dopamine was suppressed by (-)-sulpiride (p < 0.05; n = 7).

Conclusion: The DA-2 receptor was demonstrated in the human decidua. Dopamine can stimulate PGF production via this receptor.

MeSH terms

  • Decidua / chemistry*
  • Decidua / drug effects
  • Decidua / metabolism
  • Dopamine / pharmacology
  • Female
  • Humans
  • Pregnancy
  • Prostaglandins F / biosynthesis
  • Radioligand Assay
  • Receptors, Dopamine D2 / analysis*
  • Receptors, Dopamine D2 / metabolism
  • Spiperone / metabolism
  • Sulpiride / pharmacology
  • Tritium

Substances

  • Prostaglandins F
  • Receptors, Dopamine D2
  • Tritium
  • Spiperone
  • Sulpiride
  • Dopamine